Skip to content

    Wave Life Sciences (WVE) stock price & financials

    View WVE earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance50.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $9.18M
    $8.70M
    $38.25M
    +316.9%
    $2.27M
    -73.9%
    Strengthening
    Operating Profit
    -$63.91M
    $22.97M
    -$49.80M
    -$52.76M
    -$56.35M
    +11.8%
    -$56.47M
    -345.9%
    -$31.30M
    +37.2%
    -$73.80M
    -39.9%
    Weakening
    Net Profit
    -$61.78M
    $29.25M
    -$46.88M
    -$50.47M
    -$53.85M
    +12.8%
    -$53.18M
    -281.8%
    -$26.09M
    +44.4%
    -$69.36M
    -37.4%
    Weakening
    EPS
    $-0.47
    $-0.29
    $-0.31
    $-0.32
    +31.9%
    $-0.13
    +55.2%
    $-0.34
    -9.7%
    Strengthening
    Other Income
    $2.13M
    $6.29M
    $2.93M
    $2.29M
    $2.50M
    +17.1%
    $3.29M
    -47.7%
    $5.21M
    +78.1%
    $4.45M
    +94.2%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    -$61.78M
    $29.25M
    -$46.88M
    -$50.47M
    -$53.85M
    +12.8%
    -$53.18M
    -281.8%
    -$26.09M
    +44.4%
    -$69.36M
    -37.4%
    Weakening
    MarginsOPM
    -542.8%
    -606.5%
    -81.8%
    +84.9%
    -3248.3%
    -435.6%
    Weakening
    Tax
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    ReturnsROIC
    -30.1%
    14.2%
    -22.8%
    -24.6%
    -26.2%
    +12.8%
    -25.9%
    -281.8%
    -12.7%
    +44.4%
    -33.7%
    -37.4%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$174.82M$147.16M$184.50M$150.56M$88.50M$200.35M$302.08M$602.07M$368.01M
    Short-Term Investments
    Total Current Assets$202.27M$185.48M$230.04M$162.56M$98.54M$235.37M$320.39M$614.81M$507.51M
    Net PP&E$39.93M$54.47M$45.43M$40.64M$44.13M$35.72M$28.00M$19.86M$46.33M
    Goodwill
    Intangibles
    Total Assets$295.94M$284.25M$279.24M$207.01M$146.39M$274.95M$352.21M$638.50M$558.32M
    LiabilitiesTotal Current Liabilities$130.04M$118.15M$121.04M$64.20M$71.52M$186.44M$110.95M$95.06M$50.81M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$29.30M$25.59M$24.95M$32.12M$25.40M$17.77M$9.40M$40.08M
    Total Liabilities$214.72M$212.64M$188.59M$166.63M$183.60M$227.44M$134.82M$112.27M$104.80M
    EquityCommon Stock & APIC$375.15M$539.55M$694.09M$749.85M$802.83M$935.37M$1.18B$1.62B$1.63B
    Retained Earnings-$339.72M-$533.36M-$683.27M-$805.51M-$967.34M-$1.02B-$1.12B-$1.33B-$1.42B
    Total Equity$73.35M$63.73M$82.78M$32.50M-$45.09M$39.63M$209.51M$518.36M$453.52M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$22.86M-$188.23M-$115.98M-$88.99M-$127.78M-$19.43M-$151.03M-$187.49M-$191.58M
    Cash from Investing-$9.94M-$3.92M-$1.34M-$560.0K-$1.25M-$1.11M-$938.0K-$718.0K-$124.14M
    Cash from Financing$65.09M$164.40M$154.54M$55.83M$67.19M$132.53M$253.89M$488.24M$475.24M
    SummaryCapital Expenditure-$9.94M-$3.92M-$1.34M-$560.0K-$1.36M-$1.11M-$938.0K-$718.0K-$1.57M
    Free Cash Flow-$32.80M-$192.15M-$117.32M-$89.55M-$129.14M-$20.55M-$151.96M-$188.21M-$193.15M
    FCF Margin-227.6%-1202.2%-584.4%-218.6%-3539.1%-18.1%-140.3%-440.5%

    Ratios